BG Medicine, Inc. announced that Bill Densel has joined the company as general manager, CardioSCORE. In this role, he will report to president and CEO Eric Bouvier, with overall responsibility for the development and growth of CardioSCORE, BG Medicine's diagnostic blood test designed to improve the identification of individuals at high risk for near-term major cardiovascular events such as heart and stroke. Mr. Densel brings nearly two decades of developing and commercializing breakthrough technologies in medical devices, biotechnology and diagnostics to BG Medicine. He most recently served as chief executive officer of Dune Medical Devices. Prior to Dune Medical Devices, Mr. Densel held positions of increasing responsibility at Hologic Corporation.